InspireMD Net Receivables from 2010 to 2025
NSPR Stock | USD 2.44 0.07 2.79% |
Net Receivables | First Reported 2011-03-31 | Previous Quarter 2.3 M | Current Value 1.6 M | Quarterly Volatility 597.7 K |
Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 194.1 K, Interest Expense of 23.9 K or Selling General Administrative of 8.6 M, as well as many indicators such as Price To Sales Ratio of 14.95, Dividend Yield of 0.0 or PTB Ratio of 3.21. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
InspireMD | Net Receivables | Build AI portfolio with InspireMD Stock |
Latest InspireMD's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of InspireMD over the last few years. It is InspireMD's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InspireMD's overall financial position and show how it may be relating to other accounts over time.
Net Receivables | 10 Years Trend |
|
Net Receivables |
Timeline |
InspireMD Net Receivables Regression Statistics
Arithmetic Mean | 1,296,922 | |
Geometric Mean | 1,177,743 | |
Coefficient Of Variation | 43.86 | |
Mean Deviation | 481,662 | |
Median | 1,247,000 | |
Standard Deviation | 568,804 | |
Sample Variance | 323.5B | |
Range | 1.7M | |
R-Value | 0.09 | |
Mean Square Error | 343.8B | |
R-Squared | 0.01 | |
Significance | 0.74 | |
Slope | 10,834 | |
Total Sum of Squares | 4.9T |
InspireMD Net Receivables History
About InspireMD Financial Statements
InspireMD shareholders use historical fundamental indicators, such as Net Receivables, to determine how well the company is positioned to perform in the future. Although InspireMD investors may analyze each financial statement separately, they are all interrelated. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses on on InspireMD's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last Reported | Projected for Next Year | ||
Net Receivables | 2.3 M | 1.4 M |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.